Higher infant blood lead levels with longer duration of breastfeeding

Betsy Lozoff1, Elias Jimenez, Abraham W Wolf

  • 1Center for Human Growth and Development, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.

Insights

Longer breastfeeding was linked to higher infant lead levels in multiple countries and decades. This suggests monitoring lead in breastfed infants may be necessary.

Area of Science:

  • Environmental Health
  • Pediatric Nutrition
  • Toxicology

Background:

  • Infant exposure to environmental toxins is a significant public health concern.
  • Breastfeeding is widely recommended for infant nutrition and development.
  • Understanding potential risks associated with breastfeeding, such as toxin transfer, is crucial.

Purpose of the Study:

  • To investigate the association between the duration of breastfeeding and infant lead concentrations.
  • To determine if breastfeeding practices correlate with elevated lead levels in infants across different populations.

Main Methods:

  • Analysis of data from three distinct studies conducted in Costa Rica, Chile, and Detroit.
  • Assessment of the relationship between breastfeeding duration and blood lead levels using correlation coefficients.
  • Inclusion of data spanning multiple decades (1981-2003) and diverse environmental settings.

Main Results:

  • A significant positive correlation was observed between the duration of breastfeeding and infant lead concentrations across all study samples.
  • Higher breastfeeding rates were noted in Costa Rica and Chile compared to Detroit, with corresponding differences in mean lead levels.
  • Correlation coefficients (r values = 0.14-0.57) indicated a consistent association, with statistical significance (P values = .06-<.0001).

Conclusions:

  • Longer breastfeeding duration is associated with increased infant lead concentrations.
  • This association holds true across different countries, decades, and varying environmental lead exposures.
  • The findings support the consideration of monitoring lead levels in breastfed infants.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Environmental Influences on Intelligence01:29

Environmental Influences on Intelligence

Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children from...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...